title: Good evidence evaluation for good risk assessment.
authors.forename: Sophie
authors.initials: S
authors.lastname: Ignace
authors.forename: Sophie
authors.initials: S
authors.lastname: Ignace
authors.forename: Nicolas
authors.initials: N
authors.lastname: Girerd
authors.forename: Nicolas
authors.initials: N
authors.lastname: Girerd
authors.forename: Denis
authors.initials: D
authors.lastname: Fouque
mesh_terms: D000368:Aged; D006328:Cardiac Catheterization; D017023:Coronary Angiography / Q000009:adverse effects* / Q000706:statistics & numerical data; D003460:Crystallization; D017700:Embolism, Cholesterol / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000000981:diagnostic imaging* / Q000188:drug therapy; D009864:Ontario; D016032:Randomized Controlled Trials as Topic
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors